A requirement for performing robust genetic and statistical analyses on twins is correctly assigned zygosities. In order to increase the power to detect small risk factors of disease, zygosity testing should also be amenable for high throughput screening. In this study we validate and implement the use of a panel of 50 single nucleotide polymorphisms (SNPs) for reliable high throughput zygosity testing and compare it to a panel of 16 short tandem repeats (STRs). We genotyped both genomic (gDNA) and whole genome amplified DNA (WGA DNA), ending up with 47 SNP and 11 STR markers fulfilling our quality criteria. Out of 99 studied twin pairs, 2 were assigned a different zygosity using SNP and STR data as compared to self reported zygosity in a questionnaire. We also performed a sensitivity analysis based on simulated data where we evaluated the effects of genotyping error, shifts in allele frequencies and missing data on the qualitative zygosity assignments. The frequency of false positives was less than 0.01 when assuming a 1% genotyping error, a decrease of 10% of the observed minor allele frequency compared to the actual values and up to 10 missing markers. The SNP markers were also successfully genotyped on both gDNA and WGA DNA from whole blood, saliva and filter paper. In conclusion, we validate a robust panel of 47 highly multiplexed SNPs that provide reliable and high quality data on a range of different DNA templates.
By making use of the genetic variation present in the human genome it is possible to obtain unique genetic fingerprints that can discriminate between individuals (Jeffreys et al., 1985) . This also offers the most robust method for estimating the zygosity of a twin pair (Jackson et al., 2001; Ooki et al., 2004; Reed et al., 2005) . In order to obtain a reliable genetic fingerprint it is important to consider issues relating to the quality and quantity of the DNA samples available, as well as the choice of genetic markers. First, the most common way of obtaining a unique genetic fingerprint is to genotype a set of highly polymorphic short tandem repeats (STRs). However, because of their relatively large amplicon sizes compared to both single nucleotide polymorphisms (SNPs) and mini-STRs, they are prone to amplification failure and allelic imbalance due to degraded DNA (Dixon et al., 2005; Utsuno & Minaguchi 2004) . Second, the use of whole genome amplification (WGA), where the genome is amplified in order to increase the life-span and usage of individual DNA samples, has raised concerns relating to biased amplification of one allele over the other depending on the template amount and WGA method (Dean et al., 2002; Lovmar et al., 2003) . This problem is also more pronounced when using STRs over SNPs for subsequent genotyping (Bergen et al., 2005) . Third, zygosity testing should optimally be amenable for high-throughput and cost-efficient screening, in order to avoid low-powered studies and support the ever expanding twin registries and collaboration efforts (Hirschhorn et al., 2002; Ioannidis et al., 2001; Ioannidis et al., 2003; Lohmueller et al., 2003; Peltonen 2003) .
In this study we set out to evaluate and improve an already published set of 41 SNP markers ,and to validate the modified protocol for zygosity testing on genomic (gDNA), as well as WGA DNA ,using the REPLI-g kit (Dean et al., 2002; Hosono et al., 2003) on DNA extracted from whole blood and saliva. We show the utility of a highly multiplexed SNP panel for high-throughput zygosity testing and general fingerprinting, and compare it to a panel of STRs. We also consider the use of different DNA templates and WGA in the context of genetic fingerprinting and further evaluate the robustness of the SNP panel through simulation studies.
Large-Scale Zygosity Testing Using Single Nucleotide Polymorphisms
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Materials and Methods
Samples
The study was approved by the regional ethical review board at Karolinska Institutet. (Lichtenstein et al., 2002) and gDNA from 11 randomly chosen unrelated donors was collected in the form of whole blood, saliva and as blood spots on filter paper. For details concerning DNA extraction and quantification see Appendix A, Supplementary Methods.
Whole Genome Amplification
10 ng DNA was used for all WGA reactions. The DNA from the 14 trios and 24 unrelated Coriell samples were amplified using the REPLI-g Mini kit, while the DNA from the 11 unrelated donors were amplified using the REPLI-g Midi kit. Both reactions were performed according to manufacturer's protocol. Amplification of the DNA extracted from filter paper was performed according to the February 2005 supplementary protocol for filter paper samples.
Genotyping -Design of SNP Panel
The 41 SNPs as described by Petkovski et al. were used as a starting point for the design of the SNP panel. All non-HapMap SNPs (Phase I) were excluded, and SNPs genotyped by HapMap with minor allele frequencies greater than 20%, and genotypes distributed according to HWE in trios from Utah Residents with Northern and Western European Ancestry (CEU), were added, until a panel of 50 markers with no inter-marker LD, including the sex specific AMELXY marker, was obtained (Table 1) . SNPHunter (Wang et al., 2005) and RepeatMasker version open-3.1.5 (http://www.repeatmasker.org/) were used for detecting nearby SNPs and repeats in the flanking sequences, and Sequenom's Assay Design 3.4 software was used for designing multiplexes for the iPLEX chemistry.
Genotyping -SNP Method
The PCR and subsequent downstream processing was performed according to the manufacturer's standard protocol (Sequenom), and the genotypes were analyzed by an Autoflex MassARRAY mass spectrometer (Bruker Daltonics, Billerica, MA, USA). The data were analyzed independently by two persons using the SpectroTyper software (Sequenom Inc.). For details regarding genotyping and primer sequences see Appendix A, Supplementary Methods.
Genotyping -Design of STR Panel
The primer sequences in the initial multiplexing schemes were from the commercially available PowerPlex® 16 (ProMega) STR panel, as well as from primer sequences reported in UNISTS for the D19S433 (UniSTS:33588) and D2S1338 (UniSTS:30509) markers. These were used for designing a panel of 16 STR markers (Table 2) . After initial validation (see below) the final panel was reduced to 15 STR markers assayed in three multiplexes.
PCR Protocol -Microsatellite Genotyping
The PCR was performed in a 384 well format and a total volume of 5 µl using Applied Biosystems thermocyclers (See Appendix A, Supplementary Methods for details). The microsatellites were run and analyzed on a MegaBace1000 capillary sequencer (GE Healthcare). The data were analyzed independently by two persons using the Genetic Profiler version 2.2 (GE Healthcare). We failed markers that had success rates below 80% or that were out of HWE when considering adjusted α-levels. STR allele frequencies were calculated using PowerMarker version 3.2 and SNP allele frequencies, including 95% confidence intervals, were calculated in Qlikview.
Zygosity Testing
The likelihood of zygosity for the genotyped twin samples were calculated based on observed genotypes using ECLIPSE version 1.1, incorporating a prior genotyping error rate of 1% according to error model 0 (Sieberts et al., 2002) .
Simulation Studies
Genotyping data from four sets of 10,000 MZ and 10,000 DZ twin pairs each were simulated, incorporating a genotyping error (ε) of 0% for simulation I and III, and 1% for simulations II and IV (Table 3 ). The genotyping error was introduced conditional on the true genotype as presented in Table 4 . The minor allele frequencies used in simulations III and IV were decreased by 10%, while no allele frequency changes were introduced for simulations I and II (Table 3) . Missing data were simulated by randomly failing markers for each simulated twin pair. For details regarding the simulations see Appendix A, Supplementary Methods. The generated datasets were analyzed using ECLIPSE2 as described previously. Based on a likelihood ratio cut-off value of 1, we then calculated the frequency of false positives for DZ and MZ twins. A twin pair was considered a false positive if the likelihood ratio (MZ/DZ) was above 1 in the case of a DZ twin pair, and below 1 in the case of a MZ twin pair.
Results
Validation of the Marker Panels
In order to evaluate the robustness of all the 50 SNP (Table 1 ) and 16 STR (Table 2 ) markers, we performed genotyping experiments on gDNA and WGA DNA, and calculated the genotyping success rate and concordance. At each round of genotyping, we excluded markers that did not meet our quality criteria (Appendix A, Supplementary Tables 6 and 7), resulting in a final panel of 47 SNP and 11 STR markers and the additional sex specific assays. Two SNPs were rejected in the first round of genotyping, based on deviations from HWE and badly separated genotype clusters based on the allele specific peak heights. One additional SNP was rejected in the second round for a low genotyping success rate. One STR was rejected in the initial validation for a low success rate (< 80%), while two STRs were rejected in the second genotyping round for deviations from HWE. One additional STR was rejected in the second round due to low genotyping success rate (< 80%). The marker specific success rates and genotype concordances, as well as HWE p values for the SNP and the STR markers, are presented in Tables 6 and 7 .
In order to validate the SNP panel on a range of different DNA templates, we extracted DNA from 11 samples each from whole blood, saliva and blood on filter paper. The extracted DNA samples were then whole genome amplified using the REPLI-g kit, and both the gDNA and WGA samples were genotyped in Table 4 ). The gDNA extracted from filter paper resulted in the lowest genotyping success rate (66%, SD 13%) while the rest of the success rates ranged between 89% and 99%.
Zygosity Testing
Next we set out to determine the zygosity of the genotyped twin samples. In order to keep the genotyping and the quality control unbiased, the zygosity of the pairs and the gender of the individuals were unknown to the persons performing the experiments. After decoding the sample codes, we calculated the allele sharing and the odds of the likelihood ratios of a pair being monozygotic versus dizygotic for all the pairs, and compared our results with the information provided by the Swedish Twin Registry. We incorporated a prior genotyping error rate of 1% into the ECLIPSE calculations in order to account for incorrect genotypes, as well as possible somatic mutations. One pair failed the genotyping for the SNP panel and two pairs for the STR panel. Two pairs (numbers 11 and 73) gave conflicting results regarding zygosity when comparing both the SNP and STR panels to the previously assigned zygosity. Here, one of the pairs (number 11) was DZ according to the questionnaire, and MZ according to the marker panels, whereas the other pair (number 73) was DZ according to the questionnaire, and MZ according to the marker panels. The gender specific assay in the SNP panel confirmed the sex of all twin pairs, while the corresponding assay in the STR panel failed to generate successful genotypes for nine of the individuals (Appendix A, Supplementary Table 5) . Details regarding success rates and likelihood ratios of zygosity are presented in Appendix A, Supplementary Table 5 . We then performed four simulations of 10,000 MZ and 10,000 DZ pairs each to determine how sensitive the SNP panel is to genotyping error, shifts in allele frequencies and missing data. We again considered genotyping error rates of up to 1% and minor allele frequency shifts of up to -10% (Table 3) . When considering a single likelihood cut-off of 1 and no missing data, the false positive rates for DZ twins were 0.03%, 0.03%, 0.32% and 0.19% for simulations I, II, III and IV respectively. There were no false positives for MZ twins for all simulations when all markers were included. The same datasets were reanalyzed after randomly dropping out 5 or 10 of the markers, yielding false positive rates of up to 0.79% for the DZ twins and 0.02% for the MZ twins (Table 5) .
Discussion
Genotyping a set of polymorphic genetic markers yields the most robust estimates of zygosity (Jackson et al., 2001; Ooki et al., 2004; Peeters et al., 1998; Reed et al., 2005) . Other methods, like validated questionnaires, or data on chorionicity, are more imprecise, and may lead to an inflated false positive rate in association studies (Boomsma et al., 2002; Reed et al., 2005) . In this study we set out to modify and validate a set of 41 previously published SNP markers , by improving and expanding the panel to 50 markers, and including a sex specific AMELXY assay (Table 1) . Because zygosity testing and genetic fingerprinting are still often performed using STRs, we also compared the results of the SNP panel with a panel of 16 noncommerical STRs that are based on the Powerplex® 16 (Promega) and AmpFLSTR® Identifiler® (Applied Biosystems) panels (Table 2) . Previous studies have demonstrated that STR genotyping can suffer from allele drop outs or total failure of amplification due to degraded DNA or WGA DNA (Barber & Foran 2006; Bergen et al., 2005; Dixon et al., 2005; Petkovski et al., 2005) . Here we genotyped the two marker panels on both genomic and whole genome amplified DNA, and a total of 47 SNPs and 11 STRs passed our quality criteria (Tables  3 and 4 ). The fact that the STR calling requires more manual work probably explains partly the larger variation in both success rates and concordances compared to the SNP results (Appendix A, Supplementary Tables 2 and 3).
Applicability Using Different Templates
The use of optional sources for DNA, like saliva, blood on filter paper or WGA, has been shown to increase the response rate in epidemiological studies, and to facilitate the use of otherwise inaccessible biological repositories (Hannelius et al., 2005; Rylander-Rudqvist et al., 2006) . There is consequently merit in applying similar strategies when expanding twin registries or replenishing exiting DNA samples, and panels of genetic markers that are used for zygosity testing should be compatible with these kinds of DNA templates. To explore this using our SNP panel, we genotyped 11 gDNA and WGA DNA samples extracted from whole blood, saliva and blood on filter paper, using our panel of 47 Table 5 The Per Cent False Positives of Simulated MZ and DZ Twin Pairs for a Given Number of Missing Markers. SNPs. The best genotyping success rates were obtained for the gDNA from whole blood and saliva, as well as for all three WGA DNA template sources. The gDNA filter paper template worked poorly, having an overall success rate of 66% and a SD of 13% (Appendix A, Supplementary Table 4) . This is not surprising, because the method used for extracting DNA from filter paper results in at least partly fragmented DNA and low yield (Hannelius et al., 2005) . The REPLI-g kit uses its own method for extracting DNA from filter paper, and it is therefore not possible to evaluate how well the WGA reaction improved on the quality of the gDNA extracted from filter paper DNA. Previous studies concerning different WGA methods have shown that kits like REPLI-g and GenomiPhi that are based on multiple strand displacement amplification (MDA) are superior when it comes to DNA of high molecular weight. Other methods like I-PEP-L and GenomePlex prevail when degraded DNA is used as template (Dean et al., 2002; Hannelius et al., 2005; Lovmar et al., 2003; Sun et al., 2005) . Our study was not designed to compare the performance of REPLI-g with regard to degraded DNA, but results pertaining to good quality DNA and WGA amplification could be confirmed.
Zygosity Testing
We genotyped 99 twin pairs with both the SNP and the STR panels, and calculated the sib-ship likelihoods as well as per cent of allele sharing (Appendix A, Supplementary Table 5 ). When excluding twin pairs with a high proportion of missing markers, 2 pairs out of 98 for the SNP panel, and 2 pairs (numbers 11 and 73) out of 97 for the STR panel, were found to be in conflict with the zygosity assigned from questionnaire. This is in agreement with a previously estimated accuracy of 98% when using validated questionnaire (Lichtenstein et al., 2002) . Also, since the genotyping success rate for both of these pairs was 100% for the SNP and the STR panel, missing data can be excluded as a potential explanatory factor for this conflict. Consequently, both panels were equally reliable when it comes to zygosity assignment, but for large-scale studies the slightly higher failure rate, larger work burden, and higher cost for the STR analysis might pose a problem.
Here it is important to remember that we were using a noncommercial panel of STRs, and that our results regarding data quality should not be generalized to highly validated and robust commercial kits.
Simulation Studies
We have previously seen that rigorous quality controls are imperative if samples of questionable quality are used for genotyping and concurrent haplotype inference (Pulkkinen et al., 2006) . A similar notion has been raised in a study where even a 1% genotyping error was shown to have a big impact on paternity results (Hoffman & Amos 2005) . Although SNPs, due to fewer alleles and lower heterozygosity, are not as gravely affected by genotyping error as are STRs (Hoffman & Amos 2005) , we still wanted to perform a sensitivity analysis on our SNP panel, in order to investigate how the qualitative results are affected when introducing genotyping error and shifts in the assumed allele frequencies. When using ECLIPSE 2 for calculating the sib-ship likelihoods, one assumes that the allele frequencies of the population from where the twins originate are known. Based on our simulations, we could show that the false positive results of DZ twins were slightly increased when decreasing the minor allele frequency by up to 10% (Table 5) . No false positives were observed for the MZ twins. Considering that the SNPs used here are all very polymorphic (Table 1) , a decrease in the minor allele frequencies (MAF) of more than 20% might be needed to shift the DZ twin distribution enough to create a substantial overlap with the MZ twin distribution. Such a scenario would be highly unlikely, considering how comparable the allele frequencies are for the different populations examined by the HapMap consortium (Appendix A, Supplementary Table 6 ). A 1% genotyping error only marginally increased the false positive results for DZ twins. The increase in false positives of MZ twins was only visible when 5 markers were missing in combination with an allele frequency shift of -10%. When no allele frequency shift was present the genotyping error had an impact only when 10 or more markers were missing. The small effect of the genotyping error can be explained by the prior error rate assumed in our analysis. Taken together, the SNP panel seemed to be very robust to moderate changes in the assumed allele frequencies, genotyping errors of up to 1%, and missing data of up to about 20%.
Conclusions
Zygosity testing and general DNA profiling will play an increasing role in research where unambiguous identification of large sets of samples is paramount for performing reliable statistical analyses. We have presented the validation of a set of SNPs that robustly and specifically work as an attractive high throughput and cost efficient option for zygosity testing on a wide range of sample sources. Given the larger number of SNP markers compared to STRs, they provide for some added flexibility when considering the possible presence of somatic mutations and methodological, clerical and genotyping errors that may lead to missing or low quality genotypes for a smaller subset of the markers.
The simulations we performed also show the flexibility of the SNP panel as a robust framework for high throughput zygosity screening. 
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Microsatellite Genotyping
The PCR was performed in a 384 well format and a total volume of 5 µl. The PCR mix consisted of 0.2 µM forward and reverse primer (Metabion), 0.2 mM dNTP (Roche), 2.5 mM MgCl2 (Qiagen) and 0.2 U Qiagen Hotstart Taq in 1 × PCR buffer was added to 2 ng dried down DNA. The reactions were first optimized in singleplex by running a gradient PCR with 15 minutes of denaturation at 95ºC, followed by 40 cycles of 94ºC for 30 seconds, 55-65ºC for 15 seconds, and 72ºC for 30 seconds. A final elongation step of 72ºC for 5 minutes ended the program. Next, the primers were run in four multiplexes on 2.5 ng of dried down DNA (Supplementary Table 7 ) using a touch down PCR temperature profile in order to remedy some unspecific amplification observed after the singleplex run. The temperature profile started with 15 minutes of denaturation at 95ºC, followed by 13 cycles of 94ºC for 30 seconds, 72ºC (-1ºC/ cycle) for 15 seconds, and 72ºC for 30 seconds. The final 27 cycles were run using a temperature profile of 92ºC for 30 seconds, 60ºC for 15 seconds, and 72ºC for 30 seconds. A final elongation step of 72ºC for 5 minutes ended the program. Subsequent PCR:s were run using the same touch down program and the same concentrations of reagents. The DNA template amount was increased to a minimum of 10 ng when genotyping the whole genome amplified samples as well as the twin samples. The final multiplexing scheme is depicted in Supplementary Table 8. A Beckman Multimek pipetting robot was used for pipetting WGA DNA and gDNA from the twin samples. PCR reagents as well as the gDNA were pipetted using a Hamilton mph96 pipetting station. The reactions for the different markers and the same samples were pooled into 96 well plates for downstream applications using a Beckman Multimek pipetting robot. All primer sequences are available in Supplementary Table 4 . Salt was removed according to manufacturers recommendation by spinning 20 µl of the pooled samples through a Sephadex plate (GE Healthcare).
SNP Genotyping
The PCR was run in a 384 well format using BiometraT100 and Applied Biosystems 9700 thermocyclers. 4 µl of PCR mix containing 0.5 µM PCR primer 1 and 2 accordingly (MetaBion Gmbh, Martinsried, Germany), 0.5 mM dNTP (Roche Diagnostics), 3.5 mM MgCl2 (Qiagen Gmbh, Germany) and 0.5U Qiagen Hotstart Taq for the high-plex pools (> 10-plex), and 0.25 U for the low-plex pool in 1.25 × PCR buffer (Qiagen), was added to a minimum of 7.5 ng (1 µl) of DNA. All PCR reactions used the same temperature profile, with 15 minutes of denaturation at 95ºC, followed by 45 cycles of 94ºC for 30 seconds, 60ºC for 15 seconds, and 72ºC for 15 seconds. A final elongation step of 72ºC for 5 minutes ended the program. The PCR was set up using a Hamilton mph96 (Hamilton Company, Reno, NV, USA) pipetting station for pipetting of mix, and a Beckman Multimek pipetting robot for dispensing DNA template. All primer sequences are available in Supplementary Table 9 .
Unincorporated deoxynucleotides were dephosphorylted and single base extension was performed according to the Sequenom iPLEX protocol. Salt was removed by using an ion exchange resin (Sequenom), after which approximately 10 nl of the samples were spotted onto Maldimatrix containing SpectroCHIPS, and analyzed by an Autoflex MassARRAY mass spectrometer (Bruker Daltonics, Billerica, MA, USA). Data were analyzed independently by two persons using the SpectroTyper software (Sequenom Inc.).
DNA extraction
10 ml whole blood was collected in EDTA tubes and DNA extraction was performed on an Autopure LS instrument using Puregene chemistries (Gentra Systems, Inc., Mpl., MN) and the protocol for 5-10 ml whole blood. Two ml saliva was collected using Oragene DNA self-collection kit (DNA Genotek, Canada), and the samples were heated for 1h at 50ºC. DNA extraction was performed on the Autopure LS instrument using Puregene chemistries and the protocol for 1 ml cell lysate (J. Dols et. al.) . For the filter papers, a few drops of blood were applied onto FTA classic card (Whatman International Ltd.) and the blood spots were left to dry for 1 hour. Genomic DNA for genotyping was extracted using a combination of saponin and chelex-100 (Hannelius et al. 2005) , while genomic DNA for REPLI-g amplification was extracted according to the REPLI-g supplementary protocol from February 2005.
DNA Quantification
The DNA from the trios, unrelated Coriell individuals, samples from twins, and the Repli-g amplified DNA from trios and unrelated individuals were quantified using the PicoGreen (Molecular Probes Inc., Eugene, Oregon, USA) assay. The 11 DNA samples from whole blood and saliva, as well as the samples from filter paper used for the WGA reaction, were quantified by both optical density (OD) and PicoGreen. The DNA extracted from filter paper using saponin and chelex-100 was quantified by OliGreen. All corresponding whole genome amplified reactions were quantified by the PicoGreen assay.
The OD quantification was performed in an automated format using Tecan Robot Freedom evo (Tecan Nordic) and GENios spectrophotometer (Tecan Nordic). The OliGreen and PicoGreen assays (Molecular Probes Inc., Eugene, Oregon) were performed according to manufacturer's protocol, using untreated black microtiter well plates (NUNC A/S, Roskilde, Denmark), and fluorescence was measured on a FluoStar Optima (BMG LABTECH GmbH, Germany).
Simulations
The parental genotypes were generated based on allele frequencies and an assumption of HWE. The first twin was consequently generated by assuming a 50% chance of getting either one of two alleles for each marker from the parents. In case of monozygotic twins, a copy of the first twin was then produced, while in case of dizygotic twins, another individual was generated based on the same rules as for the first twin. After having generated a genotype for a specific marker and a specific twin, the genotyping error was introduced, giving each marker and each individual an equal chance of acquiring an error. Missing data were simulated by randomly excluding one marker at a time for all individuals in a simulation set. 
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Supplementary Table 5
Zygosity Assignments .37 (.23-.51) .36 (.22-.51) .85 (.76-.94) . 
SNP Results
STR Results
Pair
